Advertisement
Advertisement
U.S. markets open in 3 hours 37 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Zynex, Inc. (ZYXI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
13.96+0.31 (+2.27%)
At close: 04:00PM EST
13.62 -0.34 (-2.44%)
After hours: 04:08PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Head and Shoulders Top

Head and Shoulders Top

Previous Close13.65
Open13.65
Bid0.00 x 1000
Ask0.00 x 1200
Day's Range13.50 - 14.06
52 Week Range4.97 - 14.55
Volume136,463
Avg. Volume174,620
Market Cap537.46M
Beta (5Y Monthly)0.83
PE Ratio (TTM)29.70
EPS (TTM)0.47
Earnings DateFeb 22, 2023 - Feb 27, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateJan 05, 2022
1y Target Est18.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Undervalued
60% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for ZYXI

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Zynex, Inc.
    ZYXI: Lowering target price to $11.00ZYNEX INC has an Investment Rating of SELL; a target price of $11.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
    Rating
    Fair Value
    Economic Moat
    8 days agoArgus Research
View more
  • Simply Wall St.

    Despite recent sales, Zynex, Inc. (NASDAQ:ZYXI) insiders still hold the largest share with a 44% interest

    To get a sense of who is truly in control of Zynex, Inc. ( NASDAQ:ZYXI ), it is important to understand the ownership...

  • PR Newswire

    Zynex Medical to Participate in Piper Sandler 34th Annual Healthcare Conference

    Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that the Company's management will participate in the Piper Sandler 34th Annual Healthcare Conference. Interested parties can access the webcast on the Events section of the website at https://zynexmed.investorroom.com/ir-home on Wednesday, November 30th, 2022, at 4:30 pm ET.

  • PR Newswire

    Zynex Named as a Winner in the Deloitte 2022 Technology Fast 500TM Awards for the 4th Consecutive Year

    Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced it has been ranked 416th in revenue growth among all companies in the U.S. and Canada for revenue growth between 2018 and 2021 on Deloitte's Technology Fast 500. Zynex's revenues grew 308% over that period, with 2021 revenue reaching $130.3 million. The company estimates 2022 reve

Advertisement
Advertisement